Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315703054> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4315703054 endingPage "e293" @default.
- W4315703054 startingPage "e293" @default.
- W4315703054 abstract "Background: Impaired endothelial function predicts cardiovascular events. The aim of this study was to analyse the effect of evolocumab on endothelial function in patients with cardiovascular disease and on obligatory statin therapy. Methods: This was a prospective, double-blinded, randomized, controlled, single center study (NCT03626831) including patients with cardiovascular disease (diagnosis of coronary artery disease, non-hemorrhagic stroke, transient ischemic attack or symptomatic peripheral artery disease) and treated with statins, similar to the inclusion criteria of the FOURIER study. Patients were consecutively randomized (1:1) to either evolocumab treatment (420 mg was administrated in monthly intervals, twice during the study) or placebo. All patients underwent examination of endothelial function at baseline, and after 1, 4 and 8 weeks of treatment by a semi-automatic high-resolution ultrasound system (UNEX EF 18G; Unex Co., Nagoya, Japan). Endothelial function parameter such as flow-mediated vasodilation (FMD; vasodilator responsiveness), low flow-mediated vasocontriction (L-FMC; vasoconstrictor responsiveness) and vasoactive range (VAR; total vasomotor responsiveness) were measured. Results: 103 patients with a mean age of 66.2 (±7.7) years and a mean LDL-cholesterol of 98.2 (±19.1) mg/dl completed the study. 83.5% of the study population was known to have coronary artery disease. Endothelial function parameter (VAR) increased after 8 weeks of treatment with evolocumab compared to baseline (p = 0.034), whereas there was no significant change at 1 and 4 weeks after treatment. Moreover, an improvement in VAR from baseline at week 8 was found with evolocumab compared to placebo (p = 0.045). In a subgroup analysis, in patients with age < 67 years, lower systolic blood pressure (< 125 mmHg) or higher baseline LDL-cholesterol (> 95 mg/dl), significant evolocumab treatment effect was found in VAR improvement (p = 0.006, p = 0.049 and p = 0.042, respectively) from baseline at week 8. No serious adverse event related to study medication occurred during the study. Conclusion: Our data indicate that endothelial function could be improved with evolocumab treatment in high-risk patients with preexisting cardiovascular disease and on statin therapy. Our results contribute to the mechanistic explanation why lower incidence of the cardiovascular composite endpoint has been demonstrated in the FOURIER study." @default.
- W4315703054 created "2023-01-12" @default.
- W4315703054 creator A5005548324 @default.
- W4315703054 creator A5037731520 @default.
- W4315703054 creator A5045274623 @default.
- W4315703054 creator A5048539897 @default.
- W4315703054 creator A5049235067 @default.
- W4315703054 creator A5066875122 @default.
- W4315703054 creator A5072552734 @default.
- W4315703054 creator A5075183492 @default.
- W4315703054 creator A5091399157 @default.
- W4315703054 date "2023-01-01" @default.
- W4315703054 modified "2023-10-02" @default.
- W4315703054 title "PS-BPC02-1: PCSK-9-INHIBITOR THERAPY IMPROVES ENDOTHELIAL FUNCTION IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE" @default.
- W4315703054 doi "https://doi.org/10.1097/01.hjh.0000915720.72460.35" @default.
- W4315703054 hasPublicationYear "2023" @default.
- W4315703054 type Work @default.
- W4315703054 citedByCount "0" @default.
- W4315703054 crossrefType "journal-article" @default.
- W4315703054 hasAuthorship W4315703054A5005548324 @default.
- W4315703054 hasAuthorship W4315703054A5037731520 @default.
- W4315703054 hasAuthorship W4315703054A5045274623 @default.
- W4315703054 hasAuthorship W4315703054A5048539897 @default.
- W4315703054 hasAuthorship W4315703054A5049235067 @default.
- W4315703054 hasAuthorship W4315703054A5066875122 @default.
- W4315703054 hasAuthorship W4315703054A5072552734 @default.
- W4315703054 hasAuthorship W4315703054A5075183492 @default.
- W4315703054 hasAuthorship W4315703054A5091399157 @default.
- W4315703054 hasBestOaLocation W43157030541 @default.
- W4315703054 hasConcept C120770815 @default.
- W4315703054 hasConcept C126322002 @default.
- W4315703054 hasConcept C142724271 @default.
- W4315703054 hasConcept C164705383 @default.
- W4315703054 hasConcept C204787440 @default.
- W4315703054 hasConcept C27081682 @default.
- W4315703054 hasConcept C2777604165 @default.
- W4315703054 hasConcept C2778114629 @default.
- W4315703054 hasConcept C2778163477 @default.
- W4315703054 hasConcept C2778213512 @default.
- W4315703054 hasConcept C2780072125 @default.
- W4315703054 hasConcept C2780745583 @default.
- W4315703054 hasConcept C2780972559 @default.
- W4315703054 hasConcept C2908647359 @default.
- W4315703054 hasConcept C71924100 @default.
- W4315703054 hasConcept C84393581 @default.
- W4315703054 hasConcept C99454951 @default.
- W4315703054 hasConceptScore W4315703054C120770815 @default.
- W4315703054 hasConceptScore W4315703054C126322002 @default.
- W4315703054 hasConceptScore W4315703054C142724271 @default.
- W4315703054 hasConceptScore W4315703054C164705383 @default.
- W4315703054 hasConceptScore W4315703054C204787440 @default.
- W4315703054 hasConceptScore W4315703054C27081682 @default.
- W4315703054 hasConceptScore W4315703054C2777604165 @default.
- W4315703054 hasConceptScore W4315703054C2778114629 @default.
- W4315703054 hasConceptScore W4315703054C2778163477 @default.
- W4315703054 hasConceptScore W4315703054C2778213512 @default.
- W4315703054 hasConceptScore W4315703054C2780072125 @default.
- W4315703054 hasConceptScore W4315703054C2780745583 @default.
- W4315703054 hasConceptScore W4315703054C2780972559 @default.
- W4315703054 hasConceptScore W4315703054C2908647359 @default.
- W4315703054 hasConceptScore W4315703054C71924100 @default.
- W4315703054 hasConceptScore W4315703054C84393581 @default.
- W4315703054 hasConceptScore W4315703054C99454951 @default.
- W4315703054 hasIssue "Suppl 1" @default.
- W4315703054 hasLocation W43157030541 @default.
- W4315703054 hasLocation W43157030542 @default.
- W4315703054 hasOpenAccess W4315703054 @default.
- W4315703054 hasPrimaryLocation W43157030541 @default.
- W4315703054 hasRelatedWork W1153541708 @default.
- W4315703054 hasRelatedWork W1976523344 @default.
- W4315703054 hasRelatedWork W2023025903 @default.
- W4315703054 hasRelatedWork W2029248613 @default.
- W4315703054 hasRelatedWork W2038455119 @default.
- W4315703054 hasRelatedWork W2382709821 @default.
- W4315703054 hasRelatedWork W2389682061 @default.
- W4315703054 hasRelatedWork W2390228255 @default.
- W4315703054 hasRelatedWork W2398749982 @default.
- W4315703054 hasRelatedWork W2973567947 @default.
- W4315703054 hasVolume "41" @default.
- W4315703054 isParatext "false" @default.
- W4315703054 isRetracted "false" @default.
- W4315703054 workType "article" @default.